National Research Corporation

NRC· NASDAQ· Health Care· Health Care Equipment & Services

$19.50-0.05%

2026-08-03

Financials

Valuation Metrics

National Research Corporation's Market Cap is $439M. At end of 2025 it was $409M. Ranked #2857 of 3,112 in US market (top 92%), #1258 of 1,445 on NASDAQ (top 87%), #177 of 206 in Health Care Equipment & Services (top 86%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$439M	US#2,857/3,112 Sec#177/206
Revenue	$139M	US#2,743/3,112 Sec#181/206
Net Income	$9M	US#2,154/3,112 Sec#108/206
Total Assets	$135M	US#3,016/3,112 Sec#198/206
Net Assets	$13M	US#2,988/3,112 Sec#205/206
Value
P/E	48.65x	US#1,831/3,112 Sec#91/206
P/B	32.57x	US#2,892/3,112 Sec#196/206
P/S	3.17x	US#1,826/3,112 Sec#126/206
EV/EBITDA	18.48x	US#1,772/3,112 Sec#76/206
FCF Yield	3.97%	US#1,524/3,112 Sec#86/206
Profitability
ROE	66.94%	US#77/3,112 Sec#6/206
ROA	6.71%	US#777/3,112 Sec#49/206
Op. Margin	14.11%	US#1,293/3,112 Sec#52/206
Revenue Growth	3.73%	US#1,880/3,112 Sec#142/206
Earnings Growth	-44.32%	US#1,829/3,112 Sec#92/206
Financial Health
Debt Ratio	897.10%	US#2,724/3,112 Sec#195/206
Total Debt	$78M	US#2,444/3,112 Sec#141/206
FCF	$17M	US#2,160/3,112 Sec#136/206
Cash	$3M	US#3,028/3,112 Sec#208/206
Current Ratio	0.52x	US#2,711/3,112 Sec#206/206
Net Debt/EBITDA	2.71x	US#1,578/3,112 Sec#94/206
Dividend
Div. Yield	2.69%	US#675/3,112 Sec#8/206
Div. Growth	-4.15%	US—/3,112 Sec—/206
Performance
1Y Return	55.01%	US#887/3,112 Sec#61/206
1M Return	-12.95%	US#2,743/3,112 Sec#181/206
From 52W High	-17.65%	US#1,587/3,112 Sec#110/206
1Y MDD	-46.49%	US#2,258/3,112 Sec#135/206
Trading
Volume	104,975 shares	US#2,926/3,112 Sec#203/206
Trading Value	$2M	US#2,909/3,112 Sec#189/206
Per Share
EPS	$0.53	US#1,817/3,112 Sec#97/206
BPS	$0.64	US#2,667/3,112 Sec#188/206